Talimogene Laherparepvec 60152-0003-01
- Manufacturer
- Idt Biologika Gmbh
- Dosage Form
- Injection, Suspension
- Product Type
- Drug For Further Processing
- Marketing Start
- February 1, 2022
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Talimogene Laherparepvec | 100000000 [PFU]/mL |
Selected Package
60152-0003-01Selected40 VIAL in 1 CARTON (60152-003-01) / 1 mL in 1 VIAL